Tag: Mirati
Bristol Myers Squibb buys biotech Mirati
(AOF) – Bristol Myers Squibb announced the acquisition of the American biotech Mirati for $58.00 per share, representing a net value of $4.8 billion and up to $5.8 billion, while…
Sanofi: towards an acquisition of Mirati?
JN.L. Published on 06/10/2023 at 11:14 a.m. Photo credit © Sanofi Corporate (Boursier.com) — Mirati Therapeutics soared…
Sanofi would covet the American anticancer biotech Mirati, after two agreements this week
(AOF) – The French pharmaceutical giant Sanofi (-0.51% to 102.34 euros) would study the possibility of acquiring the American manufacturer of cancer drugs Mirati Therapeutics Inc, according to Bloomberg. The…